Personal information

Emails & domains

Verified email domains

Other IDs

Loop profile: 726171
Scopus Author ID: 55757119600

Countries

Switzerland

Activities

Collapse all

Employment (3)

Inselspital, Bern University Hospital, University of Bern: Bern, BE, CH

2015-02-01 to present | consultant (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Olgun Elicin

Inselspital, Bern University Hospital, University of Bern: Bern, Bern, CH

2013-07-01 to 2015-01-31 | post-doctorate research fellow (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Olgun Elicin

Istanbul University, Cerrahpasa Faculty of Medicine: Istanbul, TR

2008-11-01 to 2013-05-03 | resident in training (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Olgun Elicin

Funding (8)

Multiomics In Head Neck Cancer Recurrence: A personalized multi-omics discovery and validation platform for recurrent head and neck squamous cell carcinoma (POLARES)

2021-10 to 2023-12 | Grant
Kompetenzfeld MB Tumor, Precision Oncology und Tumor-2020-002, Translational Oncology, Medical Faculty, Bern University (Bern, Bern, CH)
Source: Self-asserted source
Olgun Elicin

STOPSTORM

2021-05 to 2027-05 | Grant
European Commission (Brussels, BE)
URL: https://www.stopstorm.eu
GRANT_NUMBER:

945119
Source: Self-asserted source
Olgun Elicin

Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer

2019-10 to present | Grant
Rising Tide Foundation (Schaffhausen, CH)
GRANT_NUMBER:

CCR-19-300
Source: Self-asserted source
Olgun Elicin

Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer

2019-03 to present | Grant
Krebsliga Schweiz (Bern, CH)
GRANT_NUMBER:

KLS-4567-08-2018
Source: Self-asserted source
Olgun Elicin

HEAD-MET

2019-01 to present | Grant
Stiftung für Klinisch-Experimentele Tumorforschung (Bern, Bern, CH)
URL: https://clinicaltrials.gov/study/NCT03510390
Source: Self-asserted source
Olgun Elicin

Impact of two different follow-up strategies on overall survival, oncological outcome, quality of life and economics in head and neck cancer patients after clinical complete remission — a randomized controlled prospective trial

2019-01 to 2022-01 | Grant
Swiss Cancer League (Bern, Bern, CH)
GRANT_NUMBER:

HSR-4356-11-2017
Source: Self-asserted source
Olgun Elicin

HEAD-MET

2018-07 to present | Grant
OPO-Stiftung (Bern, CH)
URL: https://clinicaltrials.gov/study/NCT03510390
GRANT_NUMBER:

2018-0067
Source: Self-asserted source
Olgun Elicin

UP-FRONT NECK Trial

2016-12 to present | Grant
Werner und Hedy Berger-Janser Stiftung (Bern, CH)
GRANT_NUMBER:

8/2016
Source: Self-asserted source
Olgun Elicin

Peer review (14 reviews for 4 publications/grants)

Review activity for Journal of cancer research and clinical oncology. (1)
Review activity for PloS one. (3)
Review activity for Radiation oncology. (8)
Review activity for Radiotherapy and oncology. (2)
How many people are using ORCID?